UnknownPhase 2NCT04183595
NBMI Treatment in Patients With Mercury Toxicity
Studying Mercury poisoning
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- EmeraMed
- Principal Investigator
- Andres Cadena-Bonfanti, MDClínica De La Costa Ltda.
- Intervention
- (N1, N3-bis(2- mercaptoethyl)isophthalamide)(drug)
- Enrollment
- 116 enrolled
- Eligibility
- 14 years · All sexes
- Timeline
- 2023 – 2024
Study locations (1)
- Clínica de la Costa Ltda., Barranquilla, Atlántico, Colombia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04183595 on ClinicalTrials.gov